A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
|Podcasts|March 24, 2023
Pharmacy Focus: Psychedelic Pharmacy - Psychedelics Are Changing the Landscape of Mental Health
This month, we spoke with expert Adi Zuloff-Shani, PhD, CEO of Clearmind Medicine.
Advertisement
This month, we spoke with expert Adi Zuloff-Shani, PhD, CEO of Clearmind Medicine, to hear about the new frontier of mental health treatments: psychedelic medicines. Clearmind is developing a novel treatment for addiction, which Zuloff-Shani said is part of a larger shift in approaches to mental health treatments.
Interested in learning more? Check out this related content:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
In an interview with Pharmacy Times, City of Hope researchers discuss a preclinical platform designed to redirect CAR T cells after infusion and how pharmacists could help bring this adaptable approach into clinical practice.
Pharmacists can explain the evidence supporting the intramuscular injection, address specific concerns, and help families understand what is known—and what is not known—about oral vitamin K.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Post hoc STEP UP data at EASD 2026 show liver fat fell from 8.8% to 3.1% at 72 weeks in a 55-person MRI subgroup, though no placebo comparison was reported.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Intensive BP Control Cuts CV Risk Regardless of CKD Status
2
Phase 3 Trial Finds Adding Monoclonal Antibody to mRNA Vaccine Improves COVID-19 Immunization Tolerability
3
When Parents Decline the Vitamin K Shot: What Every Pharmacist Needs to Know
4
Fat and Cholesterol Myths Pharmacists Should Address
5